Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 14/20 | 0.75 |
| ▸ | SLC6A2 | P23975 | 10/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.65 |
| ▸ | MLNR | O43193 | 1/20 | 0.65 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | HTR1A | P08908 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | DRD2 | P14416 | 1/20 | 0.65 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.65 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.65 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.65 |
| ▸ | HTR2A | P28223 | 1/20 | 0.65 |
| ▸ | HTR2C | P28335 | 1/20 | 0.65 |
| ▸ | MC4R | P32245 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13476291 | 1.00 | CACNA2D1 (0.75) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL2600193 | 1.00 | CACNA2D1 (0.75) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| Hydrochloric Acid SCHEMBL2587 | 0.99 | CACNA2D1 (0.73) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL20292630 | 0.87 | CACNA2D1 (0.94) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL23521652 | 0.86 | CACNA2D1 (0.67) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL21742715 | 0.86 | CACNA2D1 (0.67) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL20292670 | 0.86 | CACNA2D1 (1.00) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL20292671 | 0.86 | CACNA2D1 (1.00) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL20292579 | 0.85 | CACNA2D1 (0.84) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL21742806 | 0.85 | CACNA2D1 (0.84) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095239-A1 | A PROCESS FOR THE PREPARATION OF DULOXETINE HYDROCHLORIDE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2012-04-19 | — | — | US | disclosed |
| US-20120095239-A1 | A PROCESS FOR THE PREPARATION OF DULOXETINE HYDROCHLORIDE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2012-04-19 | — | — | US | disclosed |
| US-20110275836-A1 | PROCESS FOR THE PREPARATION OF DULOXETINE AND SALTS THEREOF | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2011-11-10 | — | — | US | disclosed |
| US-20110275836-A1 | PROCESS FOR THE PREPARATION OF DULOXETINE AND SALTS THEREOF | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2011-11-10 | — | — | US | disclosed |
| WO-2010103443-A1 | A PROCESS FOR THE PREPARATION OF DULOXETINE HYDROCHLORIDE | ALEMBIC LIMITED (IN) | 2010-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095239-A1 | A PROCESS FOR THE PREPARATION OF DULOXETINE HYDROCHLORIDE | HTR5A, BDNF, CYP3A5 | CACNA2D1 1788/4885SLC6A2 5/4885SLC6A4 6/4885 |
| US-20110275836-A1 | PROCESS FOR THE PREPARATION OF DULOXETINE AND SALTS THEREOF | BDNF, SLC6A4, SLC6A2 | CACNA2D1 2225/4885SLC6A2 3/4885SLC6A4 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.